Tag Archives: AstraZeneca

Prime Minister Narendra Modi held a meeting on Friday to review India’s vaccination strategy in which issues such as prioritization of population groups and the technological platform for the deployment of the vaccine for the coronavirus were discussed. Modi tweeted that the meeting discussed important topics related to the progress …

The Oxford-AstraZeneca vaccine for coronavirus disease could be available to the general public between April and May next year and is likely to cost around ₹ 500-600 per dose, the executive director of the Serum Institute of India said on Thursday. , Adar Poonawalla, adding that he expects the long-awaited …

Written by Prabha Raghavan | New Delhi | Updated: November 20, 2020 7:08:08 am The candidate, who is being manufactured by SII under an agreement with Oxford-AstraZeneca, is the pioneer in India’s own race to find a vaccine to defeat the novel coronavirus. (Photo of Fie) Serum Institute of India …

By James Paton The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca Plc produced strong immune responses in older adults in an initial study, and key findings are expected from the final phase of trials in the coming weeks. The results, published Thursday in the …

As the COVID-19 The case count in India rose to more than 90 lakh on Thursday, the executive director and owner of the Pune-based Serum Institute of India, Adar Poonawalla, said the country could look forward to a vaccine against the novel coronavirus by the end of the year or …

Results from the Oxford Phase 2 study show that the vaccine is better tolerated in older people. The University of Oxford confirmed that the Covid-19 vaccine it is developing with AstraZeneca Plc produced strong immune responses in older adults in a preliminary study, and key findings from the final phase …

Moderna Inc’s experimental vaccine was 94.5% effective in preventing Covid-19 based on interim data from a late-stage trial, the company said Monday, becoming the second U.S. pharmacist to report results that far exceed those. expectations. Along with Pfizer Inc’s vaccine, which is also more than 90% effective, and pending more …

The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 injection, aiming to have 100 million doses ready by December for an inoculation campaign that could begin across India later that month. If the data from the end-stage trial shows that AstraZeneca’s candidate provides effective protection against …

The world’s largest vaccine maker is ramping up production of AstraZeneca Plc’s Covid-19 injection, aiming to have 100 million doses ready by December for an inoculation campaign that could begin across India later that month. If data from the final stage of the trial shows that the AstraZeneca candidate provides …

BENGALURU: The Serum Institute of India, the world’s largest vaccine producer, said Thursday that it has manufactured 40 million doses of AstraZeneca’s potential Covid-19 vaccine and will soon start producing Novavax’s rival vaccine as both seek regulatory approval. While there are no approved Covid-19 vaccines yet and trials are still …